NineSigma, representing Merck, invites proposals for traditional herbal medicinal products that are able to treat specific health indications.
Opportunity
Product acquisition, licensing, proof of concept leading to scale-up to manufacturing, joint development, supplier agreement, contract research,
The success proposals will:
- Have proven traditional use:
- 30 years in the European Union (EU) or
- 15 years in the EU and 30 years outside the EU;
- Have safety data;
- Have few or no side effects, be non-irritating and non-addictive;
- Have data on plausibility of efficacy, ideally with clinical proof on humans;
- Be able to be incorporated in a user-friendly and modern dosage form;
- Be cost effective;
- Preferably be commercially available or at least able to be commercialised within 1-3 years.
Deadline for extended submission is 31st March 2011.
For complete details on the RfP, visit NineSigma.com or email: [email protected].
For Chinese version of the call and for other details please see the documents provided below:
Call details: Chinese version
Project description: Chinese version
Response template for non-confidential proposals: Chinese version
